CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration

Abstract

BackgroundClear, transparent, and sufficiently detailed abstracts of conferences and journal articles related to randomized controlled trials (RCTs) are important, because readers often base their assessment of a trial solely on information in the abstract. Here, we extend the CONSORT (Consolidated Standards of Reporting Trials) Statement to develop a minimum list of essential items, which authors should consider when reporting the results of a RCT in any journal or conference abstract.Methods and FindingsWe generated a list of items from existing quality assessment tools and empirical evidence. A three-round, modified-Delphi process was used to select items. In all, 109 participants were invited to participate in an electronic survey; the response rate was 61%. Survey results were presented at a meeting of the CONSORT Group in Montebello, Canada, January 2007, involving 26 participants, including clinical trialists, statisticians, epidemiologists, and biomedical editors. Checklist items were discussed for eligibility into the final checklist. The checklist was then revised to ensure that it reflected discussions held during and subsequent to the meeting. CONSORT for Abstracts recommends that abstracts relating to RCTs have a structured format. Items should include details of trial objectives; trial design (e.g., method of allocation, blinding/masking); trial participants (i.e., description, numbers randomized, and number analyzed); interventions intended for each randomized group and their impact on primary efficacy outcomes and harms; trial conclusions; trial registration name and number; and source of funding. We recommend the checklist be used in conjunction with this explanatory document, which includes examples of good reporting, rationale, and evidence, when available, for the inclusion of each item.ConclusionsCONSORT for Abstracts aims to improve reporting of abstracts of RCTs published in journal articles and conference proceedings. It will help authors of abstracts of these trials provide the detail and clarity needed by readers wishing to assess a trial's validity and the applicability of its results.

Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning

“…[62][63][64][65] Analyses were detailed in a statistical analysis plan, which was finalised prior to completion of data collection and database lock. All analyses were conducted using Stata version 13 (StataCorp LP, College Station, TX, USA).…”

Evidence comes by replication, but needs differentiation: the reproducibility issue in science and its relevance for criminology

“…Research on differentiated knowledge about reproducible findings needs to be embedded in the general framework of enhancing replication: empirical studies should adhere to the recommendations and guidelines for sound and replicated evidence that have been made in various contexts; see The Steering Group of the Campbell Collaboration (2016), the standards of the Society of Prevention Research (Gottfredson et al 2015), the recommendations of the Reproducibility Project in Psychology (Open Science Collaboration 2015), and the CONSORT standards of reporting (Hopewell et al 2008). Only a few issues can be mentioned here: evaluation studies should not only be carried out by program developers but also by independent researchers.…”

Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders

“…Art therapy is a complex intervention and, as such, it may be difficult to attribute changes in mental health outcomes to be a direct result of the intervention unless more high-quality RCTs are implemented. Figure 16 40 guidelines in conducting and reporting trials.…”

“…But does this mean that we can generalise the results from people who are referred to those who are not referred? Trials should adhere to CONSORT 40 guidelines to ensure quality in the conduct and reporting of future RCTs of art therapy. 4.…”